Target intelligence / Profile preview

CD81 antisense RNA 1 (CD81-AS1)

Target
CD81-AS1
Molecular classification
long non-coding RNA, lncRNA, antisense RNA
01

Overview

CD81 antisense RNA 1 (CD81-AS1) is a lncRNA transcribed from the DNA strand opposite to the CD81 gene. Antisense RNAs like CD81-AS1 typically regulate the expression of their corresponding sense genes (here, CD81) through mechanisms such as transcriptional interference, chromatin modification, or RNA-RNA interactions[3]. These RNAs influence gene expression at various levels, including chromatin architecture, transcription, splicing, and translation. While the general roles of lncRNAs and antisense RNAs in regulating gene expression have been well established, detailed functional characterization and disease associations of CD81-AS1 specifically require further investigation. Currently, CD81-AS1 is not considered a direct therapeutic target such as a receptor, enzyme, or transporter. If additional structured disease associations, biomarker utility, or drug interactions emerge for CD81-AS1, curation from specialized databases or recent dedicated studies would be required, since most information on antisense RNAs focuses on their mechanistic rather than clinical or therapeutic significance[3].

Other names
CD81-AS1
02

Biological functions

Regulation of gene expressiontranscriptional interferenceepigenetic regulation
03

Disease associations

Cancer (several lncRNAs, including some antisense RNAs in the CD81 locus, are implicated in oncogenesis or cancer progression based on their gene regulation roles, but specific direct disease associations for CD81-AS1 require confirmation in primary literature)

Beyond the preview

Go deeper on CD81 antisense RNA 1 (CD81-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD81 antisense RNA 1 (CD81-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call